The FDA approves updated covid vaccines with restrictions

The FDA approves updated covid vaccines with restrictions

The food and medication administration approved on Wednesday the covid-19 vaccines updated for the next autumn/winter season for some Americans.

The Pfizer-Bionntech vaccine was approved for use in adults 65 years of age or older and for those between 5 and 64 years with at least one underlying condition that puts them at high risk of severe COVID.

In Press releaseThe companies said that their vaccine 2025-2026 COVID-19 will go to a sublinage known as LP.8.1, a branch of the Jn.1 Subvariant, in line with the FDA guide to match the most closely circulation strains.

“These vaccines are available for all patients who choose them after consulting with their doctors,” wrote the Secretary of Human Health and Services, Robert F. Kennedy Jr. Publish in X. “The American people demanded science, security and common sense. This framework offers the three.”

Americans who have 6 months and more and have a high risk can receive the modern vaccine; Those 12 years or more can obtain the novavax vaccine, according to Kennedy.

Healthy children under 18 can receive a COVID-19 vaccine after consulting with a medical care provider.

The leading group of pediatricians of the American Academy of Pediatrics (AAP) in La Nación says that the FDA’s decision today about Covid vaccines, which can limit the availability of shooting for children and young adults, is “deeply worrying.”

Boxes for the Pfizer COVID-19 updated Lationnaty.

Pfizer through AP

In general, after the FDA approves vaccines, the next step is a meeting between members of the vaccine advice panel of the centers for disease control and prevention. Then, the panel makes recommendations on the use of the vaccine for the CDC, which the director of the signing agency.

In June, Kennedy eliminated the 17 members of the CDC Vaccine Advisory Committee and replaced them with their own hand -selected members, many of which have previously expressed skeptical opinions of vaccines.

The change in approval could leave some Americans facing pocket costs when receiving the COVID-19 vaccine. Insurers often trust the recommendations of the CDC vaccine panel to determine what they should cover and not cover.

If the ACIP does not recommend certain vaccines, it can take parents or guardians who face pocket costs if their children are shot. It could also mean that the shots are not covered by the Vaccines For Children (VFC) program, a program financed by the federal government that provides non -cost vaccines to eligible children.

A COVID-19 vaccine could cost more than $ 140 in the private sector, according to the CDC vaccine price list.

The approval of the FDA occurs after Kennedy announced at the end of May that the CDCs would no longer recommend COVID-19 vaccines for healthy children and healthy pregnant women. Previously, the Covid vaccine for all Americans of 6 months or more was recommended.

Then, the CDCs updated the guide to a “shared clinical decision making” model, leaving the decision to vaccinate between patients or parents and a doctor.

In response, the AAP issued its annual immunization program, recommending that children from 6 months to 23 months should receive a COVID-19 vaccine. The AAP also recommended that the ages of 2 to 18 receive a COVID vaccine if they have a high risk of severe COVID, they live in a long -term care center or a gathered environment, if they have never been vaccinated against COVID or if they live with someone with a high risk of severe COVID.

In addition, the American College of Obstetricians and Gynecologists, the main medical group that represents Ob-gyns throughout the country, last week that Patients should receive an updated COVID vaccine At any time during pregnancy, when he plans to get pregnant, in the postpartum period or when lacting.

Leave a Reply

Your email address will not be published. Required fields are marked *

nineteen + seven =

Back To Top